An open multicenter trial of conversion from Sandimmun to Neoral in stable kidney-transplant patients.
Hourmant
M
M
Service de Néphrologie, Hôtel-Dieu, Nantes, France.
Antoine
C
C
Bayle
F
F
Bedrossian
J
J
Berthoux
F
F
Cassuto
E
E
Chalopin
J M
JM
Charpentier
B
B
Deteix
P
P
Durand
D
D
Hurault de Ligny
B
B
Kessler
M
M
Kreis
H
H
Lang
P
P
Lebranchu
Y
Y
Leroux-Robert
C
C
Moulin
B
B
Mourad
G
G
Noël
C
C
Olmer
M
M
Potaux
L
L
Pouteil-Noble
C
C
Pruna
A
A
Sraër
J D
JD
Soulillou
J P
JP
D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000008:administration & dosage*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine